These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 1702944

  • 1. Assessment of nasal patency by rhinoscopic measurement of cross sectional nasal airway area: correlation with subjective nasal symptoms.
    Selner JC, Koepke JW, Staudenmayer H, Dolen WK, Glover GC, Linzmayer MI, Mooney JJ, Wiener MB.
    Ann Allergy; 1991 Jan; 66(1):43-7. PubMed ID: 1702944
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cross-sectional area of nasal airways during the nasal provocation tests.
    Olivé-Pérez A.
    Allergol Immunopathol (Madr); 1992 Jan; 20(3):101-4. PubMed ID: 1414856
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparison of montelukast and pseudoephedrine in the treatment of allergic rhinitis.
    Mucha SM, deTineo M, Naclerio RM, Baroody FM.
    Arch Otolaryngol Head Neck Surg; 2006 Feb; 132(2):164-72. PubMed ID: 16490874
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of single and multiple doses of pseudoephedrine in the treatment of nasal congestion associated with common cold.
    Eccles R, Jawad MS, Jawad SS, Angello JT, Druce HM.
    Am J Rhinol; 2005 Feb; 19(1):25-31. PubMed ID: 15794071
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Oxymetazoline nasal spray three times daily for four weeks in normal subjects is not associated with rebound congestion or tachyphylaxis.
    Watanabe H, Foo TH, Djazaeri B, Duncombe P, Mackay IS, Durham SR.
    Rhinology; 2003 Sep; 41(3):167-74. PubMed ID: 14579657
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Relationship between nasal cavity volume changes and nasalance.
    Birkent H, Erol U, Ciyiltepe M, Eadie TL, Durmaz A, Tosun F.
    J Laryngol Otol; 2009 Apr; 123(4):407-11. PubMed ID: 19000331
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A double-blind, placebo-controlled, randomized clinical study of the effects of vardenafil on human nasal patency.
    Aydin E, Hizal E, Onay O, Ozgen B, Turhan B, Zaimoglu M, Peskircioglu L, Budakoglu II.
    Am J Rhinol; 2008 Apr; 22(3):276-9. PubMed ID: 18588760
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.